Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CANO HEALTH, INC.

(CANO)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 12/01 04:37:13 pm
9.355 USD   +0.16%
11/30INSIDER BUY : Cano Health
MT
11/29MedAvail to install self-serve medication kiosks in LA area clinics
AQ
11/22CANO HEALTH : Should I Worry About My Family History with Heart Disease?
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Reverse Losses as Biotechs Rise

09/01/2021 | 03:55pm EST


ę MT Newswires 2021
All news about CANO HEALTH, INC.
11/30INSIDER BUY : Cano Health
MT
11/29MedAvail to install self-serve medication kiosks in LA area clinics
AQ
11/22CANO HEALTH : Should I Worry About My Family History with Heart Disease?
PU
11/10SUGAR, CAFFEINE, AND YOUR HEART : What You Need to Know
PU
11/10Piper Sandler Adjusts Cano Health's Price Target to $13 From $11, Maintains Neutral Rat..
MT
11/10CANO HEALTH, INC. Management's Discussion and Analysis of Financial Condition and Resu..
AQ
11/09Cano Health to Seek Tuck-In Acquisitions
CI
11/09Cano Health Reports Q3 Net Loss as Revenue Rises; Updates 2021 Outlook
MT
11/09Cano Health Announces Financial Results for the Third Quarter 2021 Increases Full Year ..
PU
11/09Q3 2021 Presentation
PU
More news
Analyst Recommendations on CANO HEALTH, INC.
More recommendations
Financials (USD)
Sales 2021 1 714 M - -
Net income 2021 -26,2 M - -
Net Debt 2021 747 M - -
P/E ratio 2021 -63,4x
Yield 2021 -
Capitalization 1 685 M 1 685 M -
EV / Sales 2021 1,42x
EV / Sales 2022 0,97x
Nbr of Employees 2 193
Free-Float 35,3%
Chart CANO HEALTH, INC.
Duration : Period :
Cano Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CANO HEALTH, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 9,20 $
Average target price 17,50 $
Spread / Average Target 90,2%
EPS Revisions
Managers and Directors
Marlow Hernandez Chairman, President & Chief Executive Officer
Brian D. Koppy Chief Financial Officer
Richard B. Aguilar Chief Clinical Officer
Carlos Zuniga Chief Technology Officer & Senior VP-Operations
David B. Armstrong Secretary & Chief Compliance Officer
Sector and Competitors